Poniard Appoints Chief Medical Officer
Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer.
Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer. Glassberg, who served as director of the company until June 2006, joined Poniard after working at the University of California, San Francisco’s (UCSF, www.ucsf.edu) Comprehensive Cancer Center, where he served as associate director of clinical care and director of general oncology.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
